Tumor characteristics of ALCL patients, according to ALK expression
| . | ALK-positive ALCL . | ALK-negative ALCL . | P4-150 . |
|---|---|---|---|
| 5% or less active caspase 3 | 10 | 29 | .002 |
| More than 5% active caspase 3 | 10 | 3 | |
| Less than 50% Bcl-2 | 24 | 23 | .001 |
| 50% or more Bcl-2 | 1 | 16 | |
| Pl9-negative | 18 | 21 | NS |
| Pl9-positive | 0 | 6 |
| . | ALK-positive ALCL . | ALK-negative ALCL . | P4-150 . |
|---|---|---|---|
| 5% or less active caspase 3 | 10 | 29 | .002 |
| More than 5% active caspase 3 | 10 | 3 | |
| Less than 50% Bcl-2 | 24 | 23 | .001 |
| 50% or more Bcl-2 | 1 | 16 | |
| Pl9-negative | 18 | 21 | NS |
| Pl9-positive | 0 | 6 |
NS indicates not significant.
As determined by the Fisher exact test.